Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019

Published on November 21, 2019

The Food and Drug Administration approved tafenoquine for prophylaxis of malaria and antirelapse therapy.

Continue reading on website
Other news

EARLY RELEASE: Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019

November 19, 2019
As rates of influenza increase, providers evaluating patients with respiratory illnesses should ask them about e-cigarette, or vaping, product use.

EARLY RELEASE: Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement - Minnesota, 2018 and 2019

November 26, 2019
This report evaluated e-cigarette, or vaping, products used by e-cigarette, or vaping, product use-associated lung injury patients and products intended for the illicit market and seized by law enforcement.